AllianceBernstein
CLPT icon

AllianceBernstein’s ClearPoint Neuro CLPT Stock Holding History

AllianceBernstein’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
26,300
+10,500
+66% +$131K ﹤0.01% 3088
2026
Q1 		$216K Hold
15,800
– – ﹤0.01% 3019
2025
Q4 		$216K Hold
15,800
– – ﹤0.01% 3040
2025
Q3 		$344K Buy
+15,800
New +$186K ﹤0.01% 2875

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

AllianceBernstein's CLPT Position: Q2 2026 in Review

AllianceBernstein increased its ClearPoint Neuro (CLPT) stake by 66% in Q2 2026, buying an estimated $131K and bringing the position to 26,300 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3088.

AllianceBernstein first reported a position in CLPT in Q3 2025 and has held it in 4 quarters since. The position peaked at $344K in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • AllianceBernstein held 26,300 shares of ClearPoint Neuro worth $239K as of Q2 2026.
  • AllianceBernstein bought 10,500 ClearPoint Neuro shares in Q2 2026, an estimated $131K.
  • ClearPoint Neuro made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3088 holding.
  • AllianceBernstein first reported a position in ClearPoint Neuro in Q3 2025 and has held it in 4 quarters since.
  • AllianceBernstein's ClearPoint Neuro position peaked at $344K in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.